Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
First Advantage Corporation (FA)
Sprinklr, Inc. (CXM)
Coliseum Acquisition (MITAU)
Upcoming IPO
Bright Health Group Inc. (BHG)
Doximity, Inc. (DOCS)
Miromatrix Medical, Inc (MIRO)
Confluent, Inc. (CFLT)
Monte Rosa Therapeutics Inc. (GLUE)
Amtd Digital, Inc. (HKD)
Unicycive Therapeutics Inc. (UNCY)
Acurx Pharmaceuticals (ACXP)
Mister Car Wash, Inc. (MCW)
Elevation Oncology, Inc. (ELEV)
Alpha Teknova, Inc. (TKNO)
Gh Research Plc (GHRS)
Graphite Bio, Inc. (GRPH)
The Glimpse Group (VRAR)
Integral Ad Science Holding Corp. (IAS)
D-MARKET Electronic Services & Trading (HEPS)
Missfresh Limited (MF)
Dingdong (cayman) Limited (DDL)
Xometry, Inc. (XMTR)
Sentinelone, Inc. (S)
Intapp, Inc. (INTA)
Cvrx, Inc. (CVRX)
Legalzoom.com, Inc. (LZ)
Clear Secure, Inc. (YOU)
Torrid Holdings, Inc. (CURV)
D-market Electronic Services & Trading (HBX)
Evercommerce Inc (EVCM)
Krispy Kreme, Inc. (DNUT)
Priced IPO
Full Truck Alliance Co. Ltd. (YMM)
Century Therapeutics, Inc (IPSC)
Atai Life Sciences B.v. (ATAI)
Femasys (FEMY)
Tremor International Ltd. (TRMR)
Cyteir Therapeutics, Inc. (CYT)
Codex Dna, Inc. (DNAY)
Aihuishou International Co. Ltd. (RERE)
Ambrx Biopharma Inc (AMAM)
iSpecimen (ISPC)
Angel Oak Mortgage, Inc. (AOMR)
Lyell Immunopharma, Inc. (LYEL)
Verve Therapeutics, Inc. (VERV)
Molecular Partners Inc. (MOLN)
Walkme Ltd. (WKME)
Convey Holding Parent, Inc. (CNVY)
Alzamend Neuro (ALZN)
Taskus, Inc. (TASK)
Janux Therapeutics, Inc. (JANX)
Kanzhun Limited (BZ)
More companies

Transcode Therapeutics (RNAZ)

Sector - Healthcare

IPO Profile

About company

Company Logo
TransCode Therapeutics is an emerging RNA oncology company, created on the belief that cancer can be defeated through the intelligent design and effective delivery of RNA therapeutics. They have created a platform of drug candidates designed to target a variety of tumor types with the objective of significantly improving patient outcomes. Their lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which causes approximately 90% of all cancer deaths representing over nine million deaths per year worldwide. They believe that TTX-MC138 has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. Their drug candidates, TTX-siPDL1 and TTX-siLIN28b, focus on the treatment of tumors by targeting PD-L1 and Lin28b, respectively. Their scientific founders developed the initial TransCode therapeutic candidate at The General Hospital Corporation, d/b/a Massachusetts General Hospital, or MGH, to target microRNA-10b, a well-validated biomarker linked to metastatic cancer. TTX-MC138 comprises proprietary iron-oxide nanoparticles and oligonucleotides that specifically target microRNA-10b.
Industry
Pharmaceutical Preparations
CEO CFO
Robert Michael Dudley Thomas A. Fitzgerald
Employees Founded
6 2016

Contacts

Address: 6 Liberty Square, #2382 Boston, Ma 02109

Telephone: (857) 837-3099

Web page: http://www.transcodetherapeutics.com

IPO information

Expected Date 5/17/2021
Status  ! Week of
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range $8.00-$10.00
Share prices ($)

Shares & Volumes

Shares Initial (MM) 6.3
Shares Revised (MM) -
Expected offer amount (MM) $25
Realized offer amount(MM) -

Financial Data (last reporting year)

Market Cap (MM) $47.88
Revenues (MM) $0
Net Income (Loss) (MM) $-2.34

Voting

What do you think will happen with the RNAZ share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: ThinkEquity

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
ThinkEquity
CO-Managers
-

Sector: Healthcare

Tweets about $RNAZ

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats